METAGENOMI, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.6 USD | +0.56% |
|
-14.49% | 0.00% |
| 14/05 | Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 07/05 | HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 135M | - | - | - | |||
| 52.5B | - | |||||
| 39.01B | ||||||
| 39.31B | ||||||
| 26.2B | ||||||
| 26.57B |
- Stock Market
- Equities
- MGX Stock
- Charts Metagenomi, Inc.
- Sector Chart
